Virus Dataset Sample Info

> Dataset: 21941645 Search Result


Summary
Item Summary
Project 21941645
Virus Name HBV/HCV
Sample Number 23
Disease cirrhosis; HCC
Country Colombia;El Salvador;Israel;Venezuela
Data Link https://www.ncbi.nlm.nih.gov/nuccore/?term=FJ589065%3AFJ589070%5Bpacc%5D
https://www.ncbi.nlm.nih.gov/nuccore/?term=JF693486%3AJF693489%5Bpacc%5D

Sample
ID Sample ID Age Gender Origin Detail
1 UdeA-001 68 F Colombia View
2 UdeA-002 59 M Colombia View
3 UdeA-003 68 M Colombia View
4 UdeA-004 47 M Colombia View
5 UdeA-006 48 M Colombia View
6 UdeA-009 69 M Colombia View
7 UdeA-015 68 F Colombia View
8 UdeA-024 60 M El Salvador View
9 UdeA-054 47 M Venezuela View
10 UdeA-056 56 F Colombia View
11 UdeA-058 53 M Colombia View
12 UdeA-061 47 F Colombia View
13 UdeA-065 58 F Colombia View
14 UdeA-069 64 F Colombia View
15 UdeA-070 34 M Colombia View
16 UdeA-072 49 M Israel View
17 UdeA-077 57 M Colombia View
18 UdeA-083 67 F Colombia View
19 UdeA-087 48 M Colombia View
20 UdeA-089 47 F Colombia View
21 UdeA-099 56 M Colombia View
22 UdeA-101 74 F Colombia View
23 UdeA-124 57 M Colombia View

Literature
Item Summary
PMID 21941645
Title Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia.
Abstract Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end-stage liver diseases in the world. A study was carried out on end-stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia. From 131 patients recruited in this prospective study, 71% of cases were diagnosed as cirrhosis, 12.2% as HCC, and 16.8% as cirrhosis and HCC. Regarding the risk factors of these patients, alcohol consumption was the most frequent (37.4%), followed by viral etiology (17.6%). Blood and/or hepatic tissue samples from patients with serological markers for HCV or HBV infection were characterized; on the basis of the phylogenetic analysis of HCV 5' UTR and HBV S gene, isolates belonged to HCV/1 and HBV/F3, respectively. These results confirm the presence of strains associated with poor clinical outcome, in patients with liver disease in Colombia; additionally, HBV basal core promoter double mutant was identified in HCC cases. Here we show the first study of cirrhosis and/or HCC in Colombian and HBV and HCV molecular characterization of these patients. Viral aetiology was not the main risk factor in this cohort but alcohol consumption.